Mario Raviglione

Director/Board Member at Global Alliance for TB Drug Development

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Melvin Spigelman	M	75	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	21 years
David Norton	M	72	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	11 years
Shalini Sharp	F	49	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	9 years
Paul Sekhri	M	66	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	-
Sangita Reddy	M	61	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	3 years
Sundar Kodiyalam	M	62	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	3 years
Kim Schwartz	F	-	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	2 years
Jane Griffiths	M	69	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	4 years
Willo Brock	M	-	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	10 years
Nancy Miller-Rich	F	65	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	6 years
Ambassador Eric Goosby	M	-	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	3 years
Ariel Pablos-Méndez	M	-	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	-
Mitchell Warren	M	-	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	-
Rasha Hibri	F	-	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	2 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Caterina Bima	F	64	University of Turin	7 years
Bruce Carter	M	80	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	-
Riccardo Montanaro	M	66	University of Turin	3 years
Paolo Gibello Ribatto	M	-	University of Turin	4 years
Paola Marini	M	66	University of Turin	4 years
Andrea Maggia	M	-	University of Turin	6 years
Lucia Morselli	M	67	University of Turin	2 years
Maria Grazia Roncarolo	M	69	University of Turin	3 years
Claudio Serracane	M	67	University of Turin	4 years
Andrea Beltratti	M	65	University of Turin	4 years
Fabio Pasquini	M	70	University of Turin	4 years
Riccardo Ranalli	M	68	University of Turin	4 years
Georgios Vlamakis	M	75	University of Turin	4 years
Gianpiero Giacardi	M	66	University of Turin	3 years
Paolo Cafasso	M	67	University of Turin	4 years
Roberto Orecchia	M	71	University of Turin	4 years
G. Botta	M	70	University of Turin	4 years
Claudio Recchi	M	69	University of Turin	4 years
Daniela Ovazza	F	67	University of Turin	4 years
Enrico Mario Amo	M	67	University of Turin	4 years
Alessandra Trombetta	F	65	University of Turin	4 years
Galeazzo Scarampi del Cairo	M	68	University of Turin	3 years
Ezio Giovanni Basso	M	69	University of Turin	4 years
Vittorio Rabajoli	M	-	University of Turin	4 years
Camillo Venesio	M	70	University of Turin	4 years
Oscar Pepino	M	71	University of Turin	4 years
Stefano Marsaglia	M	69	University of Turin	4 years
Carlo Pavesio	M	68	University of Turin	3 years
Andrea Dogliotti	M	74	University of Turin	4 years
Umberto Bocchino	M	64	University of Turin	4 years
Riccardo Lodigiani	M	66	University of Turin	4 years
Gilbert Marks	M	66	Global Alliance for TB Drug Development Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.	12 years

Statistics

Country	Connections	% of total
Italy	30	65.22%
United States	16	34.78%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections